Endosense Scores $4.3M Add-On

Endosense, a Geneva-based developer of sensing technology focused on catheter ablation for the treatment of cardiac arrhythmias, has raised $4.3 million in new funding, bringing its Series C round to $44.6 million. Endosense is backed by Edmond de Rothschild Investment Partners, Neomed, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital Partners, Initiative Capital Romandie and NGN Capital.

North AmericaUSBriefs